Pros | ![]() 3Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() Larger AUM within category. ![]() Beats FD returns for both 3Y & 5Y. | ||
Cons | - | - |
INDMoney rank | - | 9/19 | ||
Category,Subcateogry | Equity,Mid-Cap | Equity,Mid-Cap | ||
Fund Age | 7 Years | 12 Years | ||
Fund Size | 3067 Cr | 43941 Cr | ||
Min Investment | SIP ₹500 Lumpsum ₹1000 | SIP ₹100 Lumpsum ₹100 | ||
Expense Ratio | 0.49% | 0.45% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | S&P BSE Midcap TR INR | S&P BSE Midcap TR INR |
No of Holdings | 69 | 67 | ||
Top 5 Holdings | Max Healthcare Institute Ltd Ordinary Shares (3.19%) State Bank of India (2.87%) Indian Bank (2.33%) Voltas Ltd (2.2%) The Federal Bank Ltd (2.17%) | Fortis Healthcare Ltd (3.45%) Ipca Laboratories Ltd (3.39%) Mphasis Ltd (2.98%) Coromandel International Ltd (2.93%) Oberoi Realty Ltd (2.71%) | ||
No of Sectors | 11 | 13 | ||
Top 3 Sectors | Financial Services (21.59%) Consumer Cyclical (17.35%) Industrial (15.45%) | Industrial (17.33%) Consumer Cyclical (16.25%) Tech (15.89%) | ||
Equity % | 93.59% | 97.8% | ||
Debt % | - | - | ||
P/E | 21.55 | 27.83 | ||
P/B | 3.17 | 4.4 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 8.49% | 8.72% | ||
3-Month Return | -9.07% | -11.68% | ||
6-Month Return | -13.69% | -13.06% | ||
1-Year Return | 11.4% | 16.52% | ||
3-Year Return | 22.18% | 19.64% | ||
5-Year Return | 33.4% | 33.53% |
Sharpe | 0.87 | 0.72 | ||
Alpha | 1.71 | -0.08 | ||
Beta | 0.97 | 0.89 | ||
Standard Deviation | 16.84 | 15.97 | ||
Information Ratio | 0.57 | -0.29 |
Description | Mahindra Manulife Mid Cap Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | Kotak Emerging Equity Scheme Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Krishna Sanghavi,Manish Lodha | Atul Bhole |